Area of leased space Area of Real Estate Property Award Type [Axis] Award Date [Axis] Award Date [Domain] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract] Accounts payable Accounts Payable, Current Accrued expenses and other current liabilities Total accrued expenses and other current liabilities Accounts Payable and Other Accrued Liabilities, Current Accounts Expenses and Other Current Liabilities [Abstract] ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block] Legal fees Accrued Professional Fees, Current Less: Accumulated depreciation and amortization Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Additional paid-in capital Additional Paid-in Capital [Member] Additional Paid-in Capital [Member] Adjustments to reconcile net loss to net cash used in operating activities: Stock-based compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Advertising expense Stock-based compensation Share-Based Payment Arrangement, Expense Antidilutive Securities [Axis] Antidilutive Securities, Name [Domain] Anti-dilutive common equivalent shares (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Assets [Abstract] Assets, Fair Value Disclosure [Abstract] Total assets Assets, Fair Value Disclosure Assets Assets [Abstract] Total assets Assets Total current assets Assets, Current Current assets: Assets, Current [Abstract] Balance Sheet Location [Domain] Balance Sheet Location [Axis] Basis of Presentation and Principles of Consolidation Basis of Accounting, Policy [Policy Text Block] Additional milestone-based consideration Change in fair value of contingent consideration Shares issued Business Combination, Consideration Transferred, Equity Interests Issued and Issuable Total Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Prepaid expenses and other current assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets Legal fees assumed Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities Business Acquisition [Axis] Business Acquisition, Acquiree [Domain] BUSINESS COMBINATION/ACQUISITION [Abstract] Business Acquisition [Line Items] Business Combination [Abstract] Business Combination, Description [Abstract] ACQUISITION BUSINESS COMBINATION Business Combination Disclosure [Text Block] Property and equipment, net Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment Purchase Price Allocation [Abstract] Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net [Abstract] Acquisition-related costs Business Combination, Acquisition Related Costs Acquisition [Abstract] Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination [Abstract] Cash and cash equivalents Cash Flow and Supplemental Noncash Information [Abstract] Cash Flow, Operating Activities, Lessee [Abstract] Cash and cash equivalents at end of period Cash and cash equivalents at beginning of period Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Net increase (decrease) in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect Cash and cash equivalents - Money Market Cash and Cash Equivalents, Fair Value Disclosure Cash and Cash Equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Class of Warrant or Right [Axis] Class of Warrant or Right [Line Items] Class of Stock [Line Items] Number of shares to be issued upon exercise of warrant (in shares) Class of Warrant or Right, Number of Securities Called by Each Warrant or Right Class of Warrant or Right [Table] Exercise price of warrant (in dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Class of Stock [Domain] Class of Warrant or Right [Domain] Warrants outstanding (in shares) COMMITMENTS AND CONTINGENCIES [Abstract] Commitments and contingencies (Note 15) COMMITMENTS AND CONTINGENCIES Common Stock [Member] Common Stock [Member] Class A Common Stock [Member] Common Class A [Member] Class B Common Stock [Member] Common Class B [Member] Common stock, par value (in dollars per share) Common Stock Common stock, shares issued (in shares) Common Stock [Abstract] Common Stock, Number of Shares, Par Value and Other Disclosure [Abstract] Common stock, shares authorized (in shares) Common stock, shares outstanding (in shares) Reclassifications Comparability of Prior Year Financial Data, Policy [Policy Text Block] Other Commitments [Abstract] Retirement Benefits [Abstract] Comprehensive loss Computer Equipment [Member] Concentration of Credit Risk Concentration Risk, Credit Risk, Policy [Policy Text Block] Construction in Process [Member] Conversion of the convertible preferred stock into Class A and Class B common stock Conversion of Stock, Amount Converted Preferred Stock [Member] Outstanding Convertible Preferred Stock (Series A through E) [Member] Convertible Preferred Stock [Member] Unrealized losses on marketable securities Debt Securities, Trading, Unrealized Gain (Loss) Realized losses on marketable securities Debt Securities, Trading, Realized Gain (Loss) Loss on marketable securities (realized and unrealized) Debt Securities, Trading, Gain (Loss) Research and development tax credit receivables Total deferred tax liabilities Deferred Tax Liabilities, Gross Net deferred tax assets (liabilities) Deferred Tax Assets, Net Tax credit carryforwards Deferred Tax Assets, Tax Credit Carryforwards Total deferred tax assets Deferred Tax Assets, Gross Deferred Tax Assets [Abstract] Deferred Tax Assets, Gross [Abstract] Net operating loss carryforwards Deferred Tax Assets, Operating Loss Carryforwards Other Deferred Tax Assets, Other Stock-based compensation Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost Deferred Tax Liabilities [Abstract] Valuation allowance Deferred Tax Assets, Valuation Allowance Other Deferred Tax Liabilities, Other Fixed assets Deferred Tax Liabilities, Property, Plant and Equipment Operating lease right-of-use assets Deferred Tax Liabilities, Leasing Arrangements Employer matching contributions to 401(k) plan Defined Contribution Plan, Employer Discretionary Contribution Amount Depreciation and amortization Depreciation and amortization expense WARRANT LIABILITIES [Abstract] Change in fair value of warrant liabilities Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net Warrant liabilities Fair value of warrant liabilities Warrants Warrant Liabilities Derivatives, Policy [Policy Text Block] WARRANT LIABILITIES Derivatives and Fair Value [Text Block] EQUITY INCENTIVE PLAN Federal [Member] Domestic Tax Authority [Member] Due from related parties Due from Related Parties, Current Due to related parties Due to Related Parties, Current Net Loss per Share [Abstract] Earnings Per Share Reconciliation [Abstract] Net Loss per Share Earnings Per Share, Policy [Policy Text Block] Net loss per common share attributable to common stockholders, basic (in dollars per share) Basic net loss per share (in dollars per share) Net loss per common share attributable to common stockholders, diluted (in dollars per share) Diluted net loss per share (in dollars per share) NET LOSS PER SHARE NET LOSS PER SHARE [Abstract] Statutory tax rate Other Effective Income Tax Rate Reconciliation, Other Reconciling Items, Percent Valuation allowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent Stock-based compensation Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Percent State taxes, net of federal benefit Effective tax rate Effective Income Tax Rate Reconciliation, Percent Federal research and development credit Effective Income Tax Rate Reconciliation [Abstract] Outstanding Options to Purchase Common Stock [Member] Stock Options [Member] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Remaining weighted average vesting period Total unrecognized stock-based compensation expense Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Employee compensation and benefits Employee-related Liabilities, Current Stock-Based Compensation [Abstract] Laboratory and Production Equipment [Member] Equipment [Member] Equity Component [Domain] Change in fair value of warrant liabilities Fair Value Liability Transfers [Abstract] Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net [Abstract] Measurement Frequency [Axis] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value Measurement Inputs and Valuation Techniques [Table] Fair Value Measurement Inputs and Valuation Techniques [Line Items] FAIR VALUE OF FINANCIAL INSTRUMENTS [Abstract] Fair Value, Recurring and Nonrecurring [Table] Fair Value Hierarchy and NAV [Axis] Transfers into Level 3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3 Transfers into Level 3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3 Transfers out of Level 3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3 Recurring [Member] Measurement Frequency [Domain] Fair Value Hierarchy and NAV [Domain] Fair Value Asset Transfers [Abstract] Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net [Abstract] Transfers out of Level 3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 FAIR VALUE OF FINANCIAL INSTRUMENTS Level 1 [Member] Level 2 [Member] Level 3 [Member] Principal payments under finance lease obligations Finance Lease, Principal Payments Finance leases Leases [Abstract] Finance Lease, Liability [Abstract] Financial Instrument [Axis] Foreign Currency Translation and Transactions Foreign Currency Transactions and Translations Policy [Policy Text Block] Furniture and Fixtures [Member] Grantee Status [Domain] Grantee Status [Axis] Loss on disposal of fixed assets Loss on disposal of property and equipment Goodwill impairment Goodwill impairment Goodwill Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block] Goodwill Goodwill Goodwill [Abstract] Goodwill, Impaired [Abstract] Impaired Long-Lived Assets Held and Used by Type [Axis] Impaired Long-Lived Assets Held and Used, Asset Name [Domain] Impairment of Long-Lived Assets [Abstract] Impairment of Long-Lived Assets Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] Impairments Income Tax Authority, Name [Axis] Income Tax Authority, Name [Domain] Income Statement Location [Axis] INCOME TAXES [Abstract] Loss before provision for income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Income Statement Location [Domain] Income Tax Authority [Axis] INCOME TAXES CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS [Abstract] Income Tax Authority [Domain] Provision for income taxes Income Taxes Income Tax, Policy [Policy Text Block] Income Taxes [Abstract] Income Tax Uncertainties [Abstract] Increase (Decrease) in Temporary Equity [Roll Forward] Operating lease liabilities Increase (Decrease) in Operating Lease Liability Accounts payable Accrued expenses and other current liabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities Other assets Increase (Decrease) in Other Operating Assets Changes in operating assets and liabilities: Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Increase (Decrease) in Stockholders' Equity [Roll Forward] Interest expense Interest Expense Federal [Member] Internal Revenue Service (IRS) [Member] Dividend income Dividend income from marketable securities LEASES Leases Lessee, Leases [Policy Text Block] 2027 Lessee, Operating Lease, Liability, to be Paid, Year Five Thereafter Lessee, Operating Lease, Liability, to be Paid, after Year Five 2024 Lessee, Operating Lease, Liability, to be Paid, Year Two Renewal term Lessee, Operating Lease, Renewal Term Lease term Lessee, Operating Lease, Term of Contract 2026 Lessee, Operating Lease, Liability, to be Paid, Year Four 2023 Lessee, Operating Lease, Liability, to be Paid, Year One 2025 Lessee, Operating Lease, Liability, to be Paid, Year Three Less: Imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Lessee, Lease, Description [Table] Future Minimum Rental Payments under Non-cancelable Operating Lease Lessee, Operating Lease, Liability, Maturity [Table Text Block] Weighted Average Remaining Term and Discount Rate [Abstract] Lessee Disclosure [Abstract] Lessee, Lease, Description [Line Items] Operating Lease, Description [Abstract] Leases [Abstract] Lessee, Operating Lease, Description [Abstract] Total undiscounted lease payments Lessee, Operating Lease, Liability, to be Paid Lease-Related Costs [Abstract] Lease, Cost [Abstract] Total lease cost Lease, Cost Lease-Related Costs Leasehold improvements Leasehold Improvements, Gross Leasehold Improvements [Member] LEASES [Abstract] Total liabilities Liabilities, Fair Value Disclosure Liabilities [Abstract] Liabilities, Fair Value Disclosure [Abstract] Liabilities and stockholders' equity Liabilities and Equity [Abstract] Total liabilities and stockholders' equity Liabilities and Equity Total liabilities Liabilities Long-term liabilities: Total current liabilities Liabilities, Current Current liabilities: Investments in Marketable Securities Measurement Input Type [Domain] Share Price [Member] Measurement Input, Share Price [Member] Risk-Free Interest Rate [Member] Measurement Input, Risk Free Interest Rate [Member] Expected Life [Member] Measurement Input, Expected Term [Member] Measurement Input Type [Axis] Volatility [Member] Measurement Input, Price Volatility [Member] Strike Price [Member] Measurement Input, Exercise Price [Member] Cash flows from financing activities: Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities Net cash provided by (used in) investing activities Net Cash Provided by (Used in) Investing Activities Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities Investments in Marketable Securities [Abstract] Debt Securities, Trading, Gain (Loss) [Abstract] Cash flows from investing activities: Cash flows from operating activities: Numerator [Abstract] Net loss Net loss Net Income (Loss) Attributable to Parent Numerator for diluted EPS - loss attributable to common stockholders Numerator for basic EPS - loss attributable to common stockholders Recently Issued Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Supplemental disclosure of noncash information: Noncash acquisition of property and equipment Weighted-average discount rate Operating Lease, Weighted Average Discount Rate, Percent Weighted-average remaining lease term Operating Lease, Weighted Average Remaining Lease Term Operating lease liabilities Operating Lease, Liability, Noncurrent Short-term operating lease liabilities Operating Lease, Liability, Current Future Minimum Lease Payments [Abstract] Lessee, Operating Lease, Liability, to be Paid [Abstract] Lease liabilities Operating Lease, Liability Operating lease right-of-use assets Operating Lease, Right-of-Use Asset Operating cash paid to settle operating lease liabilities Operating Lease, Payments Expiration date Operating Loss Carryforwards, Expiration Date Operating lease cost Operating Lease, Cost Rent expense Operating Leases, Rent Expense, Net Loss from operations Operating Income (Loss) Operating expenses: Operating Expenses [Abstract] Total operating expenses Operating Expenses Operating Loss Carryforwards [Abstract] Tax net operating loss carryforward Operating Loss Carryforwards [Table] ORGANIZATION AND DESCRIPTION OF BUSINESS ORGANIZATION AND DESCRIPTION OF BUSINESS [Abstract] Licenses Related to Certain Intellectual Property [Abstract] Other Commitments [Abstract] Other assets Other long-term liabilities Other Liabilities, Noncurrent Other (expense), net Other Nonoperating Income (Expense) Other Other Accrued Liabilities, Current ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES [Abstract] Payment of contingent consideration - business acquisition Payment of additional milestone-based consideration for first of two milestones Payment for Contingent Consideration Liability, Financing Activities Cash paid for acquisition Business acquisition Payments to Acquire Businesses, Gross Stock issuance costs for Series E convertible preferred stock Payments of Stock Issuance Costs Purchases of marketable securities Payments to Acquire Marketable Securities Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment Plan Name [Domain] Plan Name [Axis] Preferred stock, par value (in dollars per share) Preferred stock, shares authorized (in shares) Preferred stock, shares outstanding (in shares) Preferred Stock [Abstract] Preferred Stock, Number of Shares, Par Value and Other Disclosure [Abstract] Prepaid Expenses and Other Current Assets [Member] Prepaid expenses and other current assets Aggregate gross proceeds Proceeds from Issuance of Common Stock Proceeds from issuance of Series E convertible preferred stock Proceeds from Issuance of Convertible Preferred Stock Proceeds from issuance of notes payable Proceeds from Issuance of Unsecured Debt Sales of marketable securities Proceeds from exercise of stock options Estimated useful life PROPERTY AND EQUIPMENT, NET Property, Plant and Equipment Disclosure [Text Block] Property, Plant and Equipment [Line Items] Property and Equipment, Net Property, Plant and Equipment [Table Text Block] Long-Lived Tangible Asset [Axis] PROPERTY AND EQUIPMENT, NET [Abstract] Property and equipment, net Property and equipment, net Property, Plant and Equipment, Net Property and equipment Property, Plant and Equipment, Gross Property and Equipment, Net Property, Plant and Equipment, Policy [Policy Text Block] Long-Lived Tangible Asset [Domain] Property and Equipment, Net [Abstract] Property, Plant and Equipment, Net [Abstract] Right-of-use assets obtained in exchange for lease liabilities Right-of-Use Asset Obtained in Exchange for Operating Lease Liability RELATED PARTY TRANSACTIONS [Abstract] Related Party Transaction [Line Items] Annual amount of transaction with related party Related Party Transaction, Amounts of Transaction Related Party Transactions [Abstract] Related Party Transaction, Due from (to) Related Party [Abstract] Related party expenses Related Party Transaction, Expenses from Transactions with Related Party RELATED PARTY TRANSACTIONS Related Party Transaction [Domain] Related Party [Domain] Related Party Transaction [Axis] Related Party [Axis] Payment of notes payable Repayments of Unsecured Debt Research and development Research and Development Expense Research and Development [Member] Research Tax Credit Carryforward [Member] Research and Development [Member] Research and Development Expenses [Member] Research and Development Capitalized Software Development Costs RSU Awards [Member] Outstanding Restricted Stock Units [Member] Restructuring costs Restructuring Charges Subsequent Events [Abstract] Restructuring Charges [Abstract] Percentage of workforce being terminated Restructuring and Related Cost, Number of Positions Eliminated, Period Percent Accumulated deficit Accumulated Deficit [Member] Weighted average remaining contractual term, vested and expected to vest Term Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Expected term Aggregate intrinsic value, options exercisable Weighted average remaining contractual term, options exercisable Weighted average remaining contractual term, outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Plan [Member] RSU Activity Assumptions Used to Value Option Grants Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Stock Option Activity Basic and Diluted Net Loss Per Share Assets and Liabilities Measured at Fair Value on Recurring Basis Statutory to Effective Income Tax Rate Reconciliation Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Deferred Tax Assets (Liabilities) Accrued Expenses and Other Current Liabilities Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Anti-Dilutive Common Equivalent Shares Purchase Price Allocation for Majelac Technologies LLC Schedule of Business Acquisitions, by Acquisition [Table Text Block] Schedule of Business Acquisitions, by Acquisition [Table] Stock-Based Compensation Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table] Schedule of Related Party Transactions, by Related Party [Table] Property, Plant and Equipment [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Stock by Class [Table] Selling, General and Administrative Expenses [Member] Selling, general and administrative Selling, General and Administrative Expense Selling, General and Administrative Selling, General and Administrative Expenses, Policy [Policy Text Block] Selling, General and Administrative [Abstract] Forfeited (in dollars per share) Forfeited (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Employees [Member] Vesting period Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Granted (in dollars per share) Weighted Average Grant-Date Fair Value [Abstract] Exercised (in dollars per share) Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Nonemployees [Member] Weighted Average Exercise Price [Roll Forward] Share price (in dollars per share) Share price (in dollars per share) Share Price Number of Shares Underlying RSUs [Roll Forward] EQUITY INCENTIVE PLAN [Abstract] Outstanding non-vested RSUs, ending balance (in dollars per share) Outstanding non-vested RSUs, beginning balance (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Stock-based compensation Share-Based Payment Arrangement, Noncash Expense Outstanding non-vested RSUs, ending balance (in shares) Outstanding non-vested RSUs, beginning balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Granted (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value RSU Activity [Abstract] Stock-Based Compensation [Abstract] Stock Option Activity [Abstract] Weighted Average Remaining Contractual Term and Aggregate Intrinsic Value [Abstract] Vested (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Shares available for issuance (in shares) Options exercisable (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Intrinsic value of stock options exercised Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value Options exercisable (in dollars per share) Expected volatility Risk-free interest rate Expected dividend yield Aggregate intrinsic value, vested and expected to vest Aggregate intrinsic value, outstanding, beginning balance Aggregate intrinsic value, outstanding, ending balance Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Vested and expected to vest (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Outstanding, beginning balance (in shares) Outstanding, ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Outstanding, ending balance (in dollars per share) Outstanding, beginning balance (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Weighted-average grant date fair value of options granted (in dollars per share) Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Number of Options [Roll Forward] Vested and expected to vest (in dollars per share) Award Type [Domain] Stock-Based Compensation Share-Based Payment Arrangement [Policy Text Block] Balance (in shares) Balance (in shares) Shares outstanding (in shares) Shares, Outstanding Short-term lease cost Short-Term Lease, Cost SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Software [Member] Software [Member] State [Member] CONSOLIDATED BALANCE SHEETS [Abstract] Class of Stock [Axis] Equity Components [Axis] Statement [Line Items] CONSOLIDATED STATEMENTS OF CASH FLOWS [Abstract] Statement [Table] CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) [Abstract] Conversion of the convertible preferred stock into common stock (in shares) Issuance of series E convertible preferred stock, net of issuance costs (in shares) Shares issued (in shares) Shares issued (in shares) Majelac Technologies LLC Acquisition (in shares) Stock Issued During Period, Shares, Acquisitions Issuance of series E convertible preferred stock, net of issuance costs Common stock issued upon exercise of stock options Majelac Technologies LLC Acquisition Stock Issued During Period, Value, Acquisitions Common stock issued upon exercise of stock options (in shares) Exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Stock-based compensation expense Stock or Unit Option Plan Expense Conversion of the convertible preferred stock into common stock Total stockholders' equity Balance Balance Stockholders' Equity Attributable to Parent STOCKHOLDERS' EQUITY (DEFICIT) Stockholders' equity Stockholders' Equity Attributable to Parent [Abstract] STOCKHOLDERS' EQUITY (DEFICIT) [Abstract] SUBSEQUENT EVENTS Subsequent Event [Table] Subsequent Event [Line Items] SUBSEQUENT EVENTS [Abstract] Tax Credit Carryforwards Summary of Tax Credit Carryforwards [Table Text Block] Tax Net Operating Loss Carryforwards Summary of Operating Loss Carryforwards [Table Text Block] Supplemental disclosure of cash flow information: Tax Carryforwards [Abstract] Tax Credit Carryforward [Line Items] Tax Credit Carryforward [Table] Tax Year 2021 [Member] Tax Period [Axis] Tax Period [Domain] Tax carryforward Tax Credit Carryforward, Amount Expiration date Tax Credit Carryforward, Expiration Date Tax Credit Carryforward, Name [Domain] Tax Credit Carryforward [Axis] Balance Balance Temporary Equity, Carrying Amount, Attributable to Parent Balance (in shares) Balance (in shares) Temporary Equity, Shares Outstanding Marketable securities Marketable securities Financial Instruments [Domain] Unrecognized tax benefits Uncertain tax positions Use of Estimates Use of Estimates, Policy [Policy Text Block] Increase in valuation allowance Variable lease cost Variable Lease, Cost Outstanding Warrants [Member] Warrants [Member] Warrants measurement input Warrants and Rights Outstanding, Measurement Input Warrants term Warrants and Rights Outstanding, Term Warrant Liabilities [Abstract] Warrants [Abstract] Warrants and Rights Note Disclosure [Abstract] Weighted-average shares used to compute net loss per share attributable to common stockholders, diluted (in shares) Denominator for diluted EPS - weighted-average common stock (in shares) Weighted Average Number of Shares Outstanding, Diluted Weighted-average shares used to compute net loss per share attributable to common stockholders, basic (in shares) Denominator for basic EPS - weighted-average common stock (in shares) Weighted Average Number of Shares Outstanding, Basic Denominator [Abstract] Common stock (in shares) Weighted Average Number of Shares Issued, Basic Counterparty Name [Axis] President and Chief Operating Officer [Member] Chief Operating Officer [Member] Former Chief Executive Officer [Member] Chief Executive Officer [Member] Maximum [Member] Maximum [Member] Minimum [Member] Minimum [Member] Statistical Measurement [Axis] Statistical Measurement [Axis] Statistical Measurement [Domain] Counterparty Name [Domain] Scenario [Domain] Scenario [Axis] Title of Individual [Axis] Title of Individual [Domain] Cover [Abstract] Document Type Document Annual Report Document Transition Report Entity Interactive Data Current Amendment Flag ICFR Auditor Attestation Flag Document Fiscal Year Focus Document Fiscal Period Focus Document Period End Date Entity Registrant Name Entity Central Index Key Entity File Number Entity Tax Identification Number Entity Incorporation, State or Country Code Current Fiscal Year End Date Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Shell Company Entity Filer Category Entity Small Business Entity Emerging Growth Company Entity Public Float Entity Address, Address Line One Entity Address, City or Town Entity Address, State or Province Entity Address, Postal Zip Code City Area Code Local Phone Number Entity Listings [Table] Entity Listings [Line Items] Title of 12(b) Security Trading Symbol Security Exchange Name Entity Common Stock, Shares Outstanding Auditor Name Auditor Location Auditor Firm ID Redeemable warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share [Member] Redeemable Warrants [Member] Disclosures and provisions pertaining to business combinations. Business Combination Disclosure [Table] Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Business Combination Disclosure [Line Items] ACQUISITION [Abstract] BUSINESS COMBINATION [Abstract] Majelac Technologies LLC ("Majelac") is a privately-owned company providing semiconductor packaging and integrated circuit assembly services located in Pennsylvania. Majelac Technologies Llc [Member] Majelac Technologies LLC [Member] Majelac [Member] Amount of increase (decrease) in noncurrent assets classified as other attributable to related parties. Increase (Decrease) in Other Assets, Related Parties Other assets - related party The cash inflow associated with net proceeds from the equity infusion from the Business Combination. Net Proceeds from Equity Infusion from Business Combination Net proceeds from equity infusion from the Business Combination The amount of related party promissory notes forgiven in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. Noncash or Part Noncash Acquisition, Forgiveness of Related Party Promissory Notes Forgiveness of related party promissory notes The amount of equity related transaction costs from the Business Combination in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. Noncash or Part Noncash Acquisition, Equity Related Transaction Costs from Business Combination Noncash equity issuance - business acquisition The amount of equity related warrants from the Business Combination in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. Noncash or Part Noncash Acquisition, Equity Related Warrants from Business Combination Noncash equity related warrants from the Business Combination Amount of increase (decrease) in operating lease, right-of-use assets. Increase (Decrease) in Operating Lease, Right-of-Use Assets Operating lease right-of-use assets The amount of cash received from exchange of research and development tax credits during the current period. Cash Received from Exchange of Research and Development Tax Credits Cash received from exchange of research and development tax credits The cash outflow associated with the additional purchase price consideration (fair value at the Closing Date) paid six months after the Closing date of the acquisition. Payment for Deferred Consideration Payment of deferred consideration - business acquisition Payment of additional purchase price consideration Amount of increase (decrease) in fair value of additional shares of stock to be issued 12 months after the Closing Date of the business acquisition. Business Combination, Change in Fair Value of Stock Consideration Change in fair value of stock consideration Amount of noncash contingent consideration and holdbacks in acquiring a business. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. Noncash or Part Noncash Acquisition, Noncash Contingent Consideration and Holdbacks Noncash contingent consideration and holdbacks - business acquisition The amount of cash being held back that will be paid 6 months after the Closing date. Business Combination, Cash Held Back Cash held back Value of additional shares of stock to be issued 12 months after the Closing Date less, if any, that may be required by the buyer indemnitees to satisfy any unresolved claims for indemnification. Business Combination, Additional Shares to be Issued, Value Additional shares to be issued to satisfy unresolved claims for indemnification Number of milestones associated with contingent consideration in a business combination that need to be met before payment is made. Business Combination, Contingent Consideration, Number of Milestones to be Met Number of milestones to be met The amortization period for the amount of goodwill arising from a business combination that is deductible for tax purposes measured in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Business Acquisition, Goodwill, Tax Deductible Amount, Amortization Period Amortization period for goodwill for tax purposes Fair value of contingent consideration related to the achievement of two milestones in a business combination. Business Combination, Contingent Consideration, Liability, Fair Value Disclosure Fair value of additional milestone-based consideration Period of time after Closing date of the acquisition in which additional shared will be issued, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Business Combination, Period to Issue Additional Shares after Closing Date Period to issue additional shares after Closing Date Number of milestones associated with contingent consideration in a business combination that were met. Business Combination, Contingent Consideration, Number of Milestones Met Number of milestones met Period of time after Closing date of the acquisition to hold cash withheld, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Business Combination, Period to Hold Cash Back Period to hold cash back Fair value of contingent consideration for the first of two milestones met in a business combination. Business Combination, Contingent Consideration, Milestone One, Liability, Fair Value Disclosure Fair value of additional milestone-based consideration for first of two milestones Number of additional shares of stock to be issued 12 months after the Closing Date less, if any, that may be required by the buyer indemnitees to satisfy any unresolved claims for indemnification. Business Combination, Additional Shares to be Issued, Shares Additional shares to be issued to satisfy unresolved claims for indemnification (in shares) The cash outflow associated with the reimbursement for certain recently purchased equipment associated with the acquisition of business during the period. Business Combination, Consideration Transferred, Reimbursement for purchased equipment Reimbursement for certain recently purchased equipment Tabular disclosure of estimated useful lives of property and equipment. Property Plant and Equipment, Estimated Useful Lives [Table Text Block] Useful Lives of Property and Equipment Number of redeemable warrants issued per unit issued during the Company's initial public offering. Number of warrants issued per unit issued Number of warrants issued per unit issued during IPO (in shares) Person with designation of general counsel. General Counsel [Member] General Counsel [Member] Leader of board of directors and individuals serving on the board of directors. Board of Directors Chairman and Directors [Member] Interim Executive Chairman and Two Members of Board of Directors [Member] The number of members of the board of directors receiving an award of restricted stock units (RSU). Number of Members of Board of Directors Receiving Grant of Restricted Stock Unit Number of members of board of directors receiving grant of RSU award Share instrument which is convertible to stock or an equivalent amount of cash subject to service, market and performance conditions associated with the Business Combination. Restricted Stock Units Subject to Service, Market and Performance Conditions [Member] RSU Awards Subject to Service, Market and Performance Conditions [Member] Share instrument which is convertible to stock or an equivalent amount of cash subject to service and performance conditions associated with the Business Combination. Restricted Stock Units Subject to Service and Performance Conditions [Member] RSU Awards Subject to Service and Performance Conditions [Member] Share instrument which is convertible to stock or an equivalent amount of cash subject to service and/or performance conditions associated with the Business Combination. Restricted Stock Units Subject to Service and/or Performance Condition [Member] RSU Awards Subject to Service and/or Performance Condition [Member] Amount of noncash expense (credit) for award of restricted stock (reversal of expense) under share-based payment arrangement. Restricted Stock Expense (Credit) Stock-based compensation Number of votes per common share each holder of record of shares is entitled. Common Stock, Number of Votes per Share Number of votes per share Identified as tax years prior to 2018. Pre-2018 [Member] Pre-2018 [Member] Identified as tax years after 2017. Post -2017 [Member] Post -2017 [Member] Employees and nonemployees [Abstract] Employees and Nonemployees [Abstract] Value of stock issued pursuant to Business Combination accounted for as a reverse recapitalization. Stock Issued During Period, Value, Business Combination Net equity infusion from the Business Combination Number of shares of stock issued during the period pursuant to Business Combination accounted for as a reverse recapitalization. Stock Issued During Period, Shares, Business Combination Net equity infusion from the Business Combination (in shares) Issuance costs related to new stock classified as temporary equity during the period. Temporary Equity, Stock Issued During Period, Issuance Costs Issuance of Series E convertible preferred stock, net of issuance costs Number of shares issued on conversion of temporary equity. Temporary Equity Stock Converted, Shares Issued Conversion of the convertible preferred stock into Class A and B common stock (in shares) Amount of shares issued on conversion of temporary equity. Temporary Equity Stock Converted, Shares Issued, Value Conversion of the convertible preferred stock into Class A and B common stock Number of new stock classified as temporary equity issued during the period. Temporary Equity, Stock Issued During Period, Shares, New Issues Issuance of Series E convertible preferred stock, net of issuance costs (in shares) Value of stock issued as a result of the exercise of stock options and the vesting of Restricted Stock Awards during the period. Stock Issued During Period, Value, Stock Options Exercised and Restricted Stock Awards Vested Common stock issued upon exercise of stock options and vesting of restricted stock units Number of shared issued during the period as a result of the exercise of stock options and the vesting of Restricted Stock Awards. Share-based Compensation Arrangement by Share-based Payment Award, Stock Options Exercised and Restricted Stock Awards Vested in Period Common stock issued upon exercise of stock options and vesting of restricted stock units (in shares) Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from unrealized gains (losses) on investment in debt security measured at fair value with change in fair value recognized in net income (trading). Deferred Tax Assets, Unrealized Gain (Loss) on Debt Securities, Trading, Loss on marketable securities (unrealized) Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from research or experimental expenditures. Deferred Tax Assets, Section 174 Research and Experimental Expenditures Section 174 Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from leasing arrangements. Deferred Tax Assets, Leasing Arrangements Operating lease liabilities Amount, before allocation of valuation allowances, of deferred tax asset and liability attributable to deductible differences and carryforwards. Deferred Tax Assets (Liabilities), Gross Net deferred tax assets Tabular disclosure of other Information related to operating leases, including the weighted average remaining lease term, weighted average discount rate, and certain cash flow and supplemental noncash information related to lease liabilities. Other Information Related to Leases [Table Text Block] Other Information Related to Leases Inducement awards granted pursuant to Nasdaq Rule 5635(c)(4). Inducement Awards [Member] Inducement Awards [Member] The Quantum-Si Incorporated 2021 Equity Incentive Plan (2021 Plan) provides for grants of stock options, stock appreciation rights, restricted stock, restricted stock units, and other stock or cash-based awards. Directors, officers and other employees of the Company and its subsidiaries, as well as others performing consulting or advisory services for the Company, are eligible for grants under the 2021 Plan. Quantum-Si Incorporated 2021 Equity Incentive Plan [Member] 2021 Plan [Member] The 2013 Employee, Director and Consultant Equity Incentive Plan, as amended on March 12, 2021 (the "2013 Plan") and the Quantum-Si Incorporated 2021 (the "2021 Plan"). Equity Incentive Plans 2013 and 2021 [Member] 2013 and 2021 Plans [Member] Number of grants of performance-based stock options to purchase shares of Class A common stock that are inducement awards pursuant to Nasdaq Rule 5635(c)(4). Number of grants Number of grants Grant number 1 awarded on November 9, 2022. Grant 1 Awarded November 9, 2022 [Member] Grant 1 Awarded November 9, 2022 [Member] Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time that are subject to a single performance-based condition, the completion of a financing event as defined in the option award agreement. Stock Options Subject to Performance Condition Related to Completion of Financing Event [Member] Stock Options Subject to Performance Condition Related to Completion of Financing Event [Member] Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time that are subject to service and performance conditions associated with the Business Combination. Stock Options Subject to Performance Condition Related to Business Combination [Member] Stock Options Subject to Performance Condition Related to Business Combination [Member] Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time that are subject to service and performance conditions that required the Company to announce at the Advances in Genome Biology and Technology conference ("AGBT") and commence commercial sales during the year ended December 31, 2020. Stock Options Subject to Performance Condition Related to Technology Conference [Member] Stock Options Subject to Performance Condition Related to AGBT Conference [Member] Grant number 2 awarded on November 9, 2022. Grant 2 Awarded November 9, 2022 [Member] Grant 2 Awarded November 9, 2022 [Member] Awarded November 9, 2022. Awarded November 9, 2022 [Member] Awarded November 9, 2022 [Member] Disclosure of accounting policy for prepaid expenses and other current assets. Prepaid Expenses and Other Current Assets, Policy [Policy Text Block] Prepaid Expenses and Other Current Assets Disclosure of accounting policy for convertible preferred stock. Convertible Preferred Stock [Policy Text Block] Convertible Preferred Stock HighCape Capital Acquisition Corp. is a special purpose acquisition company sponsored by HighCape Capital LP. High Cape Capital Acquisition Corp. [Member] HighCape [Member] Private investors in a public equity (PIPE). PIPE Investors [Member] PIPE Investors [Member] Certain affiliates of Foresite Capital Management, LLC (the "Foresite Funds"). Certain Affiliates of Foresite Capital Management, LLC [Member] Certain Affiliates of Foresite Capital Management, LLC [Member] Exchange ratio established pursuant to the Business Combination Agreement dated as of February 18, 2021 applied retroactively to reported shares and earnings per share available to holders of the Company's capital stock and equity awards prior to the Business Combination. Business Combination, Exchange Ratio Exchange Ratio Number of votes per share owned. Common Stock, Votes per share Votes per share Percentage of total shares of common stock that must be beneficially owned by permitted holders included in sunset provision of dual class stock structure. Common Stock, Percentage of total shares that must be beneficially owned included in sunset provision Percentage of total shares that must be beneficially owned included in sunset provision Amount of offset to lease liability recorded at the inception of the lease for the costs of leasehold improvements by the lessee. Lease Incentives Less: Lease incentives Lease incentives Facility located in New Haven, Connecticut. Facility in New Haven, Connecticut [Member] Facility in New Haven, Connecticut [Member] Number of warrants or rights exercised. Class of Warrant or Right, Exercised Warrants exercised (in shares) Redemption price per share or per unit of warrants or rights outstanding. Class of Warrant or Right, Redemption Price Warrant redemption price (in dollars per share) Period of time in which warrants may not be transferred, assigned or sold after the completion of the Business Combination, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Class of Warrant or Right, Limitation Period to Transfer, Assign or Sell Warrants Limitation period to transfer, assign or sell warrants Period to provide written notice to redeem warrants, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Notice Period to Redeem Warrants Notice period to redeem warrants Beneficial ownership percentage of the outstanding shares of the Company's Class A common stock that would allow warrants to be settled in cash upon the occurrence of a tender offer or exchange offer. Beneficial Ownership Percentage Beneficial ownership percentage Number of warrants or rights redeemed. Class of Warrant or Right, Redeemed Warrants redeemed (in shares) Period prior to the Company sending notice of redemption to warrant holders to conclude the 30 consecutive trading days that common stock price must exceed threshold price for specified number of trading days, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Period Prior to Notice of Redemption Period prior to notice of redemption Threshold number of specified trading days that common stock price must exceed threshold price within a specified consecutive trading period, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Threshold Trading Days Threshold trading days Trading day period after Company calls warrants for redemption to calculate the fair market value over the exercise price of the warrants, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Trading Day Period to Calculate Fair Market Value over Exercise Price of Warrants Trading day period to calculate fair market value over exercise price of warrants Threshold period of specified consecutive trading days that common stock price must exceed threshold price for specified number of trading days, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Threshold Consecutive Trading Days Threshold consecutive trading days Redeemable warrants with each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share. Redeemable Warrants [Member] Public Warrants [Member] Private placement of warrants to the Sponsor simultaneous with the closing of the Initial Public Offering. Private Placement Warrants [Member] Private Warrants [Member] Primary financial statement caption encompassing liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other. Accounts Payable and Other Accrued Liabilities, Current [Member] Accrued Expenses and Other Current Liabilities [Member] The Amended and Restated Technology Services Agreement (the "ARTSA") provided for the participant companies to provide other services to each other. The Company had transactions with other entities under common ownership, which included payments made to third parties on behalf of the Company. Payments Made to Third Parties Under Amended and Restated Technology Services Agreement [Member] Payments Made to Third Parties on Behalf of the Company Under ARTSA [Member] Certain services performed for the Company and each other participant company under the Amended and Restated Technology Services Agreement (the "ARTSA"), such as monthly administrative, management and technical consulting services. Monthly Services Under Amended and Restated Technology Services Agreement [Member] Monthly Services Under Amended and Restated Technology Services Agreement [Member] Month-to-month sublease arrangements for office and laboratory spaces. Month-to-Month Sublease Arrangements for Office and Laboratory Spaces [Member] Month-to-Month Sublease Arrangements for Office and Laboratory Spaces [Member] The Amended and Restated Technology Services Agreement (the "ARTSA") provided for the participant companies to provide other services to each other. The Company had transactions with these other entities under common ownership which included payments made by the Company to third parties on behalf of the other entities. Payments Made to Third Parties on Behalf of Other Entities Under Amended and Restated Technology Services Agreement [Member] Payments Made to Third Parties on Behalf of Other Entities Under ARTSA [Member] The Binders Collaboration (Collaboration) develops technology and methods in the field of nanobodies and potentially other binders to produce novel biological reagents and related data. The Collaboration is made pursuant to and governed by the Technology and Services Exchange Agreement, effective as of June 10, 2021, by and among the Company and the participants named therein, including Protein Evolution, Inc. Binders Collaboration [Member] Collaboration [Member] The Company utilizes and subleases office and laboratory space in building owned by a related party. Leasing of Office and Laboratory Space [Member] Leasing of Office and Laboratory Space [Member] Under the Executive Chairman Agreement, Jonathan M. Rothberg, Ph.D, provides consulting services to the Company. He also receives fees as the Company's Chairman of the Board of Directors and a member of the Nominating and Corporate Governance Committee. Executive Chairman Agreement [Member] Executive Chairman Agreement [Member] Primary financial statement caption encompassing liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Accounts Payable, Current [Member] Accounts Payable [Member] Entity under common ownership with the Company. Catalyzer4 Corporation [Member] 4C [Member] Related party that leases office and laboratory in a building owned by the related party. Related Party [Member] Related Party [Member] Protein Evolution Inc. (PEI) develops proteins that address problems in climate change and healthcare. Protein Evolution, Inc. [Member] PEI [Member] Other participant companies in the Amended and Restated Technology Services Agreement (the "ARTSA") controlled by the Rothberg family. Other Companies Controlled by Rothberg Family [Member] Other Companies Controlled by Rothberg Family [Member] Jonathan M. Rothberg, Ph.D., is the founder of Legacy Quantum-Si and Executive Chairman of the Company ("Dr. Rothberg"). Dr. Jonathan M. Rothberg [Member] Dr. Rothberg [Member] Amount of cash outflow for payments to related party. Related Party Transaction, Payments Payments to related party The number of shares of Class A common stock that can be purchased with an option to be granted as of the date of the second business day following the Company's earnings call with respect to the fiscal year ended December 31, 2022 pursuant to an Advisory Agreement. Share-Based Compensation Arrangement by Share-Based Payment Award, Shares that can be Purchased with Option to be Granted Number of shares that can be purchased with option to be granted (in shares) Effective October 1, 2022, the Company entered into a Protein Engineering Collaboration (the "New Collaboration") with PEI to develop technology and methods in the field of nanobodies and potentially other binders to produce novel biological reagents and related data. Protein Engineering Collaboration [Member] New Collaboration [Member] Amount of annual fixed payments under licenses for certain intellectual property. Other Commitment, Annual Minimum Fixed Payments Annual minimum fixed payments Carrying value as of the balance sheet date of the obligations incurred through that date and payable for acquisition-related fees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Accrued Acquisition-Related Fees, Current Business acquisition costs and contingencies Carrying value as of the balance sheet date of the obligations incurred through that date and payable for contracted services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Accrued Contracted Services, Current Contracted services Property and equipment disposed of by the Company. Property and Equipment Disposals [Member] Disposals of Property and Equipment [Member] Designated tax department of California entitled to levy and collect income taxes from the entity. California [Member] Designated tax department of Connecticut entitled to levy and collect income taxes from the entity. Connecticut [Member] Percentage of certain research and development tax credit carryforwards exchanged for a cash payment. Research and Development Tax Credit Carryforward, Percentage Exchanged for Cash Payment Percentage of research and development tax credit carryforwards exchanged for cash Net tax benefit from the exchange of certain research and development tax credit carryforwards for a cash payment of 65% of the research and development tax credit in the state of Connecticut. Research and Development Tax Credit Carryforward, Net Benefit from Exchange Program Net benefit from exchange of research and development tax credit carryforwards Other tax credit carryforwards arising from certain qualifying expenditures incurred to develop new products and processes. Other Tax Credit Carryforwards [Member] Other Credits [Member] Space located at 115 Munson Street in New Haven, Connecticut. Space Located in New Haven, Connecticut [Member] Space Located in New Haven, Connecticut [Member]